Cargando…

Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants

Lipidic implants are valuable controlled delivery systems that present good biocompatibility and are useful for long-lasting therapies. However, these promising systems can present inflexible drug release profiles that limit their performance. Thus, finding new materials to overcome this drawback is...

Descripción completa

Detalles Bibliográficos
Autores principales: Júlio, Ana, Sultane, Anaisa, Viana, Ana Silveira, Mota, Joana Portugal, Santos de Almeida, Tânia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401770/
https://www.ncbi.nlm.nih.gov/pubmed/34452124
http://dx.doi.org/10.3390/pharmaceutics13081163
_version_ 1783745630020042752
author Júlio, Ana
Sultane, Anaisa
Viana, Ana Silveira
Mota, Joana Portugal
Santos de Almeida, Tânia
author_facet Júlio, Ana
Sultane, Anaisa
Viana, Ana Silveira
Mota, Joana Portugal
Santos de Almeida, Tânia
author_sort Júlio, Ana
collection PubMed
description Lipidic implants are valuable controlled delivery systems that present good biocompatibility and are useful for long-lasting therapies. However, these promising systems can present inflexible drug release profiles that limit their performance. Thus, finding new materials to overcome this drawback is crucial. Herein, lipidic implants containing caffeine and poorly soluble salicylic acid and rutin were developed. The inclusion of Gelucire(®) 50/02, sucrose, and two biobased ionic liquids, [Cho][Phe] and [Cho][Glu], were evaluated as a mean to improve the performance of the systems. The formulation procedure, dye content distribution, drug content, drug release, water content, and lipidic erosion of the developed systems were assessed. AFM analysis of the implants containing ILs was also performed. The results demonstrated that neither Gelucire(®) 50/02 nor sucrose were suitable tools to improve the drug release profile. In contrast, the ILs proved to be promising materials for multiple reasons; not only did they facilitate the formulation and incorporation of the studied drugs into the implants, but they also allowed a more suitable release profile, with [Cho][Glu] allowing a higher drug release due to its ability to increase surface wrinkling. Hence, this study showcases ILs as multitalented materials in lipid-based drug implants.
format Online
Article
Text
id pubmed-8401770
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84017702021-08-29 Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants Júlio, Ana Sultane, Anaisa Viana, Ana Silveira Mota, Joana Portugal Santos de Almeida, Tânia Pharmaceutics Article Lipidic implants are valuable controlled delivery systems that present good biocompatibility and are useful for long-lasting therapies. However, these promising systems can present inflexible drug release profiles that limit their performance. Thus, finding new materials to overcome this drawback is crucial. Herein, lipidic implants containing caffeine and poorly soluble salicylic acid and rutin were developed. The inclusion of Gelucire(®) 50/02, sucrose, and two biobased ionic liquids, [Cho][Phe] and [Cho][Glu], were evaluated as a mean to improve the performance of the systems. The formulation procedure, dye content distribution, drug content, drug release, water content, and lipidic erosion of the developed systems were assessed. AFM analysis of the implants containing ILs was also performed. The results demonstrated that neither Gelucire(®) 50/02 nor sucrose were suitable tools to improve the drug release profile. In contrast, the ILs proved to be promising materials for multiple reasons; not only did they facilitate the formulation and incorporation of the studied drugs into the implants, but they also allowed a more suitable release profile, with [Cho][Glu] allowing a higher drug release due to its ability to increase surface wrinkling. Hence, this study showcases ILs as multitalented materials in lipid-based drug implants. MDPI 2021-07-28 /pmc/articles/PMC8401770/ /pubmed/34452124 http://dx.doi.org/10.3390/pharmaceutics13081163 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Júlio, Ana
Sultane, Anaisa
Viana, Ana Silveira
Mota, Joana Portugal
Santos de Almeida, Tânia
Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants
title Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants
title_full Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants
title_fullStr Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants
title_full_unstemmed Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants
title_short Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants
title_sort biobased ionic liquids as multitalented materials in lipidic drug implants
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401770/
https://www.ncbi.nlm.nih.gov/pubmed/34452124
http://dx.doi.org/10.3390/pharmaceutics13081163
work_keys_str_mv AT julioana biobasedionicliquidsasmultitalentedmaterialsinlipidicdrugimplants
AT sultaneanaisa biobasedionicliquidsasmultitalentedmaterialsinlipidicdrugimplants
AT vianaanasilveira biobasedionicliquidsasmultitalentedmaterialsinlipidicdrugimplants
AT motajoanaportugal biobasedionicliquidsasmultitalentedmaterialsinlipidicdrugimplants
AT santosdealmeidatania biobasedionicliquidsasmultitalentedmaterialsinlipidicdrugimplants